These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1339521)

  • 1. A retrospective study on the treatment and evolution of Graves' ophthalmopathy.
    Simescu M; Dumitrescu C; Balmeş E; Ursu H; Vaida E; Vârciu M; Voiculescu G; Huţanu M
    Rom J Endocrinol; 1992; 30(3-4):149-58. PubMed ID: 1339521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in graves' ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves' disease from 2 prospective, randomized, open-label, blinded end point studies.
    Chen DY; Schneider PF; Zhang XS; Luo XY; He ZM; Chen TH
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):1-6. PubMed ID: 24203649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission.
    Eckstein AK; Lax H; Lösch C; Glowacka D; Plicht M; Mann K; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):607-12. PubMed ID: 17880407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graves' ophthalmopathy and 131I therapy.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hyperthyroidism due to Graves' disease: a retrospective analysis of 1,000 inpatient cards.
    Simescu M; Balmes E; Ursu HI; Voiculescu G; Popa S
    Rom J Endocrinol; 1993; 31(3-4):97-105. PubMed ID: 7697068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
    Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.
    Tanda ML; Piantanida E; Liparulo L; Veronesi G; Lai A; Sassi L; Pariani N; Gallo D; Azzolini C; Ferrario M; Bartalena L
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1443-9. PubMed ID: 23408569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between management of hyperthyroidism and course of the ophthalmopathy.
    Bartalena L; Tanda ML; Piantanida E; Lai A; Pinchera A
    J Endocrinol Invest; 2004 Mar; 27(3):288-94. PubMed ID: 15165006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiotherapy for Graves' ophthalmopathy].
    Kuhnt T; Müller AC; Janich M; Gerlach R; Hädecke J; Duncker GI; Dunst J
    Klin Monbl Augenheilkd; 2004 Nov; 221(11):915-21. PubMed ID: 15562354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
    Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA
    Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment.
    Villagelin D; Romaldini JH; Santos RB; Milkos AB; Ward LS
    Thyroid; 2015 Dec; 25(12):1282-90. PubMed ID: 26414885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe endocrine ophthalmopathy. A review with case reports].
    Barth A; Bosshard C; Bürgi U; Bürgi H
    Schweiz Med Wochenschr; 1991 Jan; 121(1-2):3-9. PubMed ID: 1899292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of radiation therapy in the treatment of Graves' orbitopathy.
    Matthiesen C; Thompson JS; Thompson D; Farris B; Wilkes B; Ahmad S; Herman T; Bogardus C
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):117-23. PubMed ID: 21030157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy.
    Wiersinga WM; Smit T; Schuster-Uittenhoeve AL; van der Gaag R; Koornneef L
    Ophthalmologica; 1988; 197(2):75-84. PubMed ID: 3186212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood Graves' ophthalmopathy: results of a European questionnaire study.
    Krassas GE; Segni M; Wiersinga WM
    Eur J Endocrinol; 2005 Oct; 153(4):515-21. PubMed ID: 16189172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graves'-Basedow's disease--asthma association. Presentation of five cases.
    Ursu HI; Pereţianu D; Bulandra T; Cucu C; Grigorie D
    Rom J Endocrinol; 1993; 31(1-2):89-94. PubMed ID: 8173579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy.
    Elbers L; Mourits M; Wiersinga W
    Thyroid; 2011 Mar; 21(3):279-83. PubMed ID: 21190446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.